Masamitsu Shimazawa

13.7k total citations
382 papers, 11.2k citations indexed

About

Masamitsu Shimazawa is a scholar working on Molecular Biology, Ophthalmology and Neurology. According to data from OpenAlex, Masamitsu Shimazawa has authored 382 papers receiving a total of 11.2k indexed citations (citations by other indexed papers that have themselves been cited), including 192 papers in Molecular Biology, 111 papers in Ophthalmology and 61 papers in Neurology. Recurrent topics in Masamitsu Shimazawa's work include Retinal Diseases and Treatments (79 papers), Retinal Development and Disorders (75 papers) and Glaucoma and retinal disorders (58 papers). Masamitsu Shimazawa is often cited by papers focused on Retinal Diseases and Treatments (79 papers), Retinal Development and Disorders (75 papers) and Glaucoma and retinal disorders (58 papers). Masamitsu Shimazawa collaborates with scholars based in Japan, United States and Australia. Masamitsu Shimazawa's co-authors include Hideaki Hara, Kazuhiro Tsuruma, Shinsuke Nakamura, Yoshimi Nakajima, Satoshi Mishima, Yuta Inokuchi, Toru Iwama, Yoshiki Kuse, Hiroshi Izuta and Shinichi Yoshimura and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Stroke.

In The Last Decade

Masamitsu Shimazawa

376 papers receiving 11.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masamitsu Shimazawa Japan 56 4.8k 2.3k 1.7k 1.2k 1.2k 382 11.2k
Hideaki Hara Japan 68 8.3k 1.7× 3.0k 1.3× 2.9k 1.8× 3.1k 2.5× 1.8k 1.5× 567 19.4k
Kazuhiro Tsuruma Japan 45 2.6k 0.5× 994 0.4× 942 0.6× 631 0.5× 560 0.5× 166 5.9k
Anu Kauppinen Finland 51 4.6k 0.9× 1.9k 0.8× 1.1k 0.6× 361 0.3× 635 0.5× 125 9.9k
Antero Salminen Finland 79 10.0k 2.1× 2.3k 1.0× 2.1k 1.3× 1.2k 1.0× 2.0k 1.7× 265 20.5k
António Francisco Ambrósio Portugal 48 2.4k 0.5× 1.7k 0.7× 1.6k 1.0× 1.3k 1.0× 278 0.2× 191 6.3k
Salvatore Salomone Italy 44 2.5k 0.5× 835 0.4× 785 0.5× 697 0.6× 280 0.2× 157 6.6k
Mark A. Yorek United States 45 3.6k 0.7× 499 0.2× 715 0.4× 774 0.6× 929 0.8× 168 11.0k
Ken‐ichi Hosoya Japan 46 2.5k 0.5× 802 0.4× 995 0.6× 900 0.7× 936 0.8× 217 7.5k
Walter J. Lukiw United States 66 8.3k 1.7× 492 0.2× 2.4k 1.4× 1.0k 0.8× 292 0.2× 254 14.9k
Takuji Shirasawa Japan 59 5.4k 1.1× 397 0.2× 382 0.2× 590 0.5× 960 0.8× 209 10.4k

Countries citing papers authored by Masamitsu Shimazawa

Since Specialization
Citations

This map shows the geographic impact of Masamitsu Shimazawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masamitsu Shimazawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masamitsu Shimazawa more than expected).

Fields of papers citing papers by Masamitsu Shimazawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masamitsu Shimazawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masamitsu Shimazawa. The network helps show where Masamitsu Shimazawa may publish in the future.

Co-authorship network of co-authors of Masamitsu Shimazawa

This figure shows the co-authorship network connecting the top 25 collaborators of Masamitsu Shimazawa. A scholar is included among the top collaborators of Masamitsu Shimazawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masamitsu Shimazawa. Masamitsu Shimazawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Watanabe, Shimpei, et al.. (2025). The anti-angiogenic effects of arctigenin on choroidal neovascularization pathogenesis. Journal of Pharmacological Sciences. 158(1). 42–51.
2.
Nakamura, Shinsuke, Yuta Inokuchi, Hiroto Abe, et al.. (2024). The protective effect of anti-VEGF-A/Ang-2 bispecific antibody on retinal vein occlusion model mice. European Journal of Pharmacology. 976. 176691–176691. 2 indexed citations
3.
Nakamura, Shinsuke, Tasuku Hirayama, Hideko Nagasawa, et al.. (2024). Both hemoglobin and hemin cause damage to retinal pigment epithelium through the iron ion accumulation. Journal of Pharmacological Sciences. 155(2). 44–51. 2 indexed citations
4.
Nakamura, Shinsuke, et al.. (2024). H-151, a Selective STING Inhibitor, Has Potential as a Treatment for Neovascular Age-Related Macular Degeneration. Investigative Ophthalmology & Visual Science. 65(8). 16–16. 8 indexed citations
5.
Tsuji, Shohei, Shinsuke Nakamura, Yoshiki Kuse, et al.. (2024). Intranasal administration of liposomes: Potential brain delivery with prospective ophthalmic reach. Journal of Drug Delivery Science and Technology. 101. 106254–106254. 1 indexed citations
6.
Kuse, Yoshiki, et al.. (2023). Progranulin deficiency exacerbates cardiac remodeling after myocardial infarction. FASEB BioAdvances. 5(10). 395–411. 3 indexed citations
7.
Nishinaka, Anri, Kei Takahashi, Takeshi Kubota, et al.. (2023). Intake of <i>Lactobacillus Pentosus TJ515</i> Prevents the Formation of Retinal Edema in Retinal Vein Occlusion Model Mice. 6(2). 47–54. 1 indexed citations
8.
Inagaki, Satoshi, et al.. (2023). ALK5 inhibitor acts on trabecular meshwork cell and reduces intraocular pressure. Experimental Eye Research. 227. 109382–109382. 2 indexed citations
9.
Imai, Takahiko, Shohei Tsuji, Takuya Ohba, et al.. (2021). Involvement of Cerebral Blood Flow on Neurological and Behavioral Functions after Subarachnoid Hemorrhage in Mice. Journal of Stroke and Cerebrovascular Diseases. 30(9). 105952–105952. 6 indexed citations
10.
Imai, Takahiko, Tetsuya Yamada, Yusuke Egashira, et al.. (2020). Importance of CBF measurement to exclude concomitant cerebral infarction in the murine endovascular perforation SAH model. Journal of Stroke and Cerebrovascular Diseases. 29(11). 105243–105243. 2 indexed citations
11.
Tsuruma, Kazuhiro, et al.. (2017). Rimonabant, a selective cannabinoid 1 receptor antagonist, protects against light-induced retinal degeneration in vitro and in vivo. European Journal of Pharmacology. 803. 78–83. 13 indexed citations
12.
Tsuruma, Kazuhiro, et al.. (2017). The involvement of ATF4 and S-opsin in retinal photoreceptor cell damage induced by blue LED light.. PubMed Central. 23. 52–59. 15 indexed citations
13.
Yoshino, Yuta, Shogo Takeda, Kazuya Toda, et al.. (2017). Fermented Rice Germ Extract Alleviates Morphological and Functional Damage to Murine Gastrocnemius Muscle by Inactivation of AMP-Activated Protein Kinase. Journal of Medicinal Food. 20(10). 969–980. 6 indexed citations
14.
Masuda, Tomomi, et al.. (2016). Edaravone is a free radical scavenger that protects against laser-induced choroidal neovascularization in mice and common marmosets. Experimental Eye Research. 146. 196–205. 18 indexed citations
15.
Tsuruma, Kazuhiro, et al.. (2015). The effect of GPNMB on muscular atrophy caused by ALS. 1. 1 indexed citations
16.
Egashira, Yusuke, Yukiya Suzuki, Toshinori Takagi, et al.. (2013). The growth factor progranulin attenuates neuronal injury induced by cerebral ischemia-reperfusion through the suppression of neutrophil recruitment. Journal of Neuroinflammation. 10(1). 105–105. 109 indexed citations
17.
Inoue, Yuki, Kazuhiro Tsuruma, Tomohiro Nakanishi, et al.. (2013). Role of Heparin-Binding Epidermal Growth Factor–Like Growth Factor in Light-Induced Photoreceptor Degeneration in Mouse Retina. Investigative Ophthalmology & Visual Science. 54(6). 3815–3815. 12 indexed citations
18.
Yamauchi, Mika, Kazuhiro Tsuruma, Shunsuke Imai, et al.. (2010). Crocetin prevents retinal degeneration induced by oxidative and endoplasmic reticulum stresses via inhibition of caspase activity. European Journal of Pharmacology. 650(1). 110–119. 122 indexed citations
19.
Izuta, Hiroshi, Yuichi Chikaraishi, Masamitsu Shimazawa, Satoshi Mishima, & Hideaki Hara. (2007). 10‐Hydroxy‐2‐decenoic Acid, a Major Fatty Acid from Royal Jelly, Inhibits VEGF‐Induced Angiogenesis in Human Umbilical Vein Endothelial Cells. Evidence-based Complementary and Alternative Medicine. 6(4). 489–494. 88 indexed citations
20.
Sasaoka, Masaaki, et al.. (2001). Effects of Lomerizine, a Novel Ca 2+ Channel Blocker, on the Normal and Endothelin-1-disturbed Circulation in the Optic Nerve Head of Rabbits. Journal of Ocular Pharmacology and Therapeutics. 17(2). 131–149. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026